OpenAI led a 250 million USD seed round for Merge Labs at an 850 million USD valuation. The startup...
The AMW Read
The article introduces a high-valuation BCI startup (Merge Labs) and a strategic involvement from a top-tier lab (OpenAI), signaling a structural shift toward biological-AI integration that transcends the healthcare vertical.
NoveltySignificance
Healthcare & Bio · Player Map
OpenAI led a 250 million USD seed round for Merge Labs at an 850 million USD valuation. The startup builds non-invasive BCI technology using ultrasound to connect neurons to AI without surgery. This signifies a systemic shift from external devices toward deep biological-AI integration. The partnership combines foundation models with neurobiology to make human cognitive enhancement the primary interface for superintelligent systems. 🧠🔬🚀
